Bioavailability of Phlorotannins and Carotenoids Following the Intake of Crackers Fortified With Seaweed
BIO-ALGA
Evaluation of the Bioavailability of Phlorotannins and Carotenoids Following the Intake of Crackers Fortified With Himanthalia Elongata
2 other identifiers
interventional
10
1 country
1
Brief Summary
The study aims to evaluate the bioavailability of phlorotannins and carotenoids from the seaweed Himanthalia elongata in healthy individuals after the consumption of a cracker fortified with this plant species. The study consists of an acute, blinded, randomized, controlled, crossover trial in which each participant consumes both the fortified cracker and a control cracker without seaweed. This design allows the comparison of the bioavailability of these compounds when incorporated into a bakery-based food matrix.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 16, 2026
CompletedFirst Posted
Study publicly available on registry
April 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
CompletedApril 2, 2026
March 1, 2026
15 days
March 5, 2026
March 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Targeted metabolic analysis of phlorotannins in blood/urine samples
Targeted metabolomic analysis of phlorotannins in plasma and urine samples will be conducted using HPLC-QTOF-MS. Quantification of the concentration (μM) will be carried out employing authentic commercial standards, ensuring accurate and reliable measurement of target compounds.
2 moths
Secondary Outcomes (5)
Targeted metabolic analysis of carotenoids in blood/urine samples.
2 months
Maximum concentration in blood of metabolites
2 month
Area under the curve (AUC) of metabolites in blood samples
2 moths
Time to maximum concentration (Tmax)
2 month
Urinary excretion percentage of metabolites
2 months
Study Arms (2)
Seaweed cracker
EXPERIMENTALRice flour, wheat flour, cornstarch, Himanthalia elongata (0.94 g), salt, sesame, mannitol, baking powder, olive oil.
Control cracker
PLACEBO COMPARATORRice flour, wheat flour, cornstarch, salt, sesame, mannitol, baking powder, olive oil
Interventions
Eligibility Criteria
You may qualify if:
- Body mass index: 18-30 Kg/m2
You may not qualify if:
- Following a vegetarian diet
- Being pregnant
- Suffering from digestive diseases (such as irritable bowel syndrome, gastrointestinal ulcers, etc.)
- Having a history of hypersensitivity or allergies to components of the study foods
- Following any medication regimen
- Currently taking or having recently taken antibiotics
- Having donated blood within the three months prior to the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Food Science, Technology and Nutrition, Spanish National Research Council (ICTAN-CSIC)
Madrid, Madrid, 28040, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Scientific Researcher
Study Record Dates
First Submitted
March 5, 2026
First Posted
April 2, 2026
Study Start
March 1, 2026
Primary Completion
March 16, 2026
Study Completion
June 1, 2026
Last Updated
April 2, 2026
Record last verified: 2026-03